Pathogenic pathways of CKD-induced anemia include relative erythropoietin deficiency, aggregation of uremic-induced erythropoiesis inhibitors, shortened RBC survival, and impaired iron metabolism by hepcidin as a fundamental mechanism of CKD-induced anemia [32, 33]. The gene discussed is HAMP; the disease is chronic kidney disease.